Chemomab Therapeutics (CMMB) Current Leases (2019 - 2025)
Chemomab Therapeutics (CMMB) posted Current Leases of $113000.0 for Q1 2025, down 1.74% on a QoQ basis from $115000.0 in Q4 2024, and up 2.73% year-over-year from $110000.0 in Q1 2024.
Chemomab Therapeutics (CMMB) Current Leases (2019 - 2025) Analysis & Trends
Chemomab Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $113000.0 for Q1 2025.
- Quarterly Current Leases rose 2.73% year-over-year to $113000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $113000.0 (up 2.73% YoY) and the FY2024 annual result came in at $115000.0, up 51.32% from the prior year.
- Current Leases was $113000.0 for Q1 2025 at Chemomab Therapeutics, down from $115000.0 in the prior quarter.
- Across five years, Current Leases topped out at $132000.0 in Q2 2022 and bottomed at $61000.0 in Q3 2021.
- A 5-year average of $104000.0 and a median of $110000.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2021 — Current Leases tumbled 64.74% — and 2022, when it jumped 106.56%.
- Chemomab Therapeutics' Current Leases stood at $106000.0 in 2021, then rose by 16.04% to $123000.0 in 2022, then tumbled by 38.21% to $76000.0 in 2023, then surged by 51.32% to $115000.0 in 2024, then declined by 1.74% to $113000.0 in 2025.
- Business Quant data shows CMMB's Current Leases at $113000.0 in Q1 2025, $115000.0 in Q4 2024, and $112000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Chemomab Therapeutics | 124.14 Mn | 113.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 113,000.00 |
| Dec 31, 2024 | 115,000.00 |
| Sep 30, 2024 | 112,000.00 |
| Jun 30, 2024 | 109,000.00 |
| Mar 31, 2024 | 110,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Sep 30, 2023 | 105,000.00 |
| Jun 30, 2023 | 108,000.00 |
| Mar 31, 2023 | 115,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Sep 30, 2022 | 126,000.00 |
| Jun 30, 2022 | 132,000.00 |
| Mar 31, 2022 | 116,000.00 |
| Dec 31, 2021 | 106,000.00 |
| Sep 30, 2021 | 61,000.00 |
| Jun 30, 2021 | 72,000.00 |
| Mar 31, 2021 | 69,000.00 |
| Dec 31, 2020 | 70,000.00 |
| Sep 30, 2020 | 173,000.00 |
| Jun 30, 2020 | 168,000.00 |